[Peculiar increase of plasma plasminogen activator inhibitor 1 levels in patients with hemophagocytic histiocytosis]

Rinsho Ketsueki. 1990 Jan;31(1):127-8.
[Article in Japanese]

Abstract

There was a markedly significant increase of plasma levels of tissue-type plasminogen activator, plasminogen activator inhibitor 1 (PAI-1) and PAI activity in 3 patients with hemophagocytic histiocytosis (HPH) as compared with DIC patients with multi-organ failure (MOF). Of particular interest was the peculiar increase of PAI-1 levels, that is, the average PAI-1 level was 2,673 ng/ml, while that in DIC patients with MOF was 66 ng/ml. We conclude that the striking increase of plasma PAI-1 levels may be a pathognomonic feature of HPH and may contribute to the pathogenesis of DIC and/or MOF associated with HPH.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Disseminated Intravascular Coagulation / blood
  • Female
  • Histiocytosis, Non-Langerhans-Cell / blood*
  • Humans
  • Male
  • Middle Aged
  • Multiple Organ Failure / blood
  • Plasminogen Inactivators / blood*

Substances

  • Plasminogen Inactivators